�����ƽ��

In drug discovery, the kidney is known for high-volume drug processing and is a critical consideration for both renal safety assessment and disease modeling. Human in vitro kidney models allow you to evaluate nephrotoxicity, transporter activity, and metabolic handling of compounds, supporting assessment of renal clearance, accumulation risk, and mechanisms of kidney injury. These systems support more confident renal safety assessment and mechanistic understanding early in drug development.

For gynecological research, new approach methodologies (NAMs), especially in vitro reproductive organoid models, enable you to focus on disease modeling and fertility studies by providing mechanistic insight into tissue function and dysfunction. The ability of these systems to recapitulate the in vivo environment and function allow you to investigate tissue-specific responses related to hormonal regulation, fertility, and gynecologic disease modeling, such as endometriosis.

By integrating functional and molecular data from these physiologically relevant urogenital models, you can strengthen biomarker discovery, better predict renal and reproductive outcomes, and make more confident decisions in therapeutic development and disease modeling.

Explore in vitro urogenital system tools for your NAM development.